Reviews
Summary
Positives
- As an ARB, candesartan blocks angiotensin II at the AT1 receptor and is included in the same therapeutic class that Long COVID cardiology reviews recommend for endothelial and microclot phenotypes PMC.
Negatives
- Candesartan is not specifically named in major Long COVID, POTS, or dysautonomia treatment reviews, which more often cite midodrine, fludrocortisone, beta blockers, or low-dose naltrexone AAFP.
Hurdles & Side Effects
- Drugs.com warnings note candesartan can cause dizziness, fainting on standing, hyperkalemia with chest pain or weakness, and is contraindicated in pregnancy, all relevant safety issues for the dysautonomic Long COVID population Drugs.com.
Was this summary accurate?
Tell us how this treatment affected you
Patient reviews are the engine that keeps this page helpful. Whether you improved tremendously, got worse, or landed somewhere in between, your story helps someone with similar conditions make a more intelligent decision.
Find care
Get Candesartan
Providers
0 matches
No linked providers yet.
Pharmacies
0 matches
No linked pharmacies yet.